Uncategorized
Experts explore protocols for switching anti-VEGFs
WAILEA, Hawaii – There is little evidence published to help guide clinicians in making the decision to switch from one anti-VEGF therapy to another. Panelists at a round table that focused on the treatment of wet age-related macular degeneration addressed that topic at Retina 2015.“I look at the glide path to dryness,” Philip J. Rosenfeld, MD, PhD,said. “I anticipate it’s going to look better with each sequential monthly injection. You can make the argument that there are those ‘late gainers’ [of improvement], but most patients improve with those first few (Read more...)